Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
boston blog main
boston top stories
bristol-myers squibb
clinical data
clinical trials
genfit
1
×
gilead sciences
intercept pharmaceuticals
ldl-c
life sciences
liver
liver disease
1
×
madrigal pharmaceuticals
1
×
mark pruzanski
nash
national blog main
national top stories
new york
new york blog main
new york top stories
nonalcoholic steatohepatitis
obeticholic acid
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
viking therapeutics
What
approved
data
disease
drug
fatty
horizon
intercept
known
liver
marketed
medicine
1
×
nash
1
×
new
nonalcoholic
steatohepatitis
track
1
×
Language
Current search:
track
×
medicine
×
genfit
×
" madrigal pharmaceuticals "
×
" liver disease "
×
nash
×
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug